Comparative analysis of markers of prêterai birth;Analisi comparativa dei marcatori di parto pretermine

Acta Biomedica de l'Ateneo Parmense

Volumn 71, Issue SUPPL. 1, 2000, Pages 331-336

  Paternoster, Delia Maria ^a,b   Bertoldini, Margherita ^a,b   Pignataro, Rosaria ^a,b   Stella, Andrea ^a,b   Bracciante, Roberto ^a,b  

^a Università di Pailova   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FFN PROTEIN, HUMAN; FIBRONECTIN; GLYCOPROTEIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; METABOLISM; PHOSPHORYLATION; PREDICTION AND FORECASTING; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR;

ADULT; BIOLOGICAL MARKERS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; OBSTETRIC LABOR, PREMATURE; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PREGNANCY;

EID: 0034572427     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS: Preterm labor. Tech. Bull, n 206, June 1995
2. CRESY R.K.: Preterm birth prevention: where are we now? dm. V. Obstet. Gynecol. 168, 1223, 1993
3. FARON G., BOULVAIN M., IRIO.V O., BERNARD P.M., FRASER W.D.: Prediction of preterm delivery by fetal fibronectin: 'a meta-analysis. Obstet. Gynecol. 92, 153, 1998
4. FEIBERG R.F., KLIMAN H.J., LOCKWOOD C.J.: Is oncofetal fibronectin a trofloblast glue for human implantation? Am. J. Pliatol. 138, 537, 1991
5. GOLDENBERG R.L., MERCER B.M., MEIS P.J., et al.: The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet. Gynecol. 87, 643, 1996
6. GREENHAGEN J.B., VAN WAGONER J., DUDLEY D., et al.: Value of fetal fibronectin as a predictor of preterm delivery for a low- risk population. Am. J. Obstet. Gynecol. 175, 1054, 1996
7. GuiBOURDENCHE J., LUTON D., ANDRE E., NOEL , PoRQUET D.:Rapid detection of insulin-like growth factor- binding protein-1 and foetal fibronectin in cervico-vaginal secretions to diagnose premature membrane rupture. Ann. Clin. Biochem. 36, 388, 1999
8. HELLEMANS P., GERRIS J., VERDONK P.: Fetal fibronectin detection for prediction of preterm birth in low risk women. Br. J. Obstet. Gynecol. 102, 207, 1995
9. KRAMER M.S.: Preventing preterm birth: are we making progress? Prenat. Neonat. Alecl. 3, 10, 1998
10. LEESON S.C., MARESII M.J., MARTINDALE E.A., et al.: Detection of fetal fibronectin as a predictor of preterm delivery in high risk symptomatic pregnancies. Br. J. Obstet. Gynecol. 103, 48, 1996
11. LOCKWOOO J.C., WEIN R., CHIEN D., et al.: Fetal membrane rupture is associated with the presence of Insulinlike growth factor binding protein-1 in vaginal secretion. Am. J. Obstet. Gynecol. 171, 146, 1994
12. MATSURRA H., HAKAMORI S.: The oncofetal domain of fibronectin defined by monoclonal antibody FDC6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc. Nat. Acad. Sei. U.S. 82, 6517, 1985
13. PATERNOSTER D., PIGNATARO R., GRELLA P.: Insulin-like growth factor protein test (IGFBP-1) in predicting preterm delivery. From Labor and Delivery, 375378,May 1997, Rome, Italy
14. RUTANEN E.M., KARKKAIEN T.H., LEIITOVIRTA J., et al.: Evaluation of rapid strip test for Insulin- like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. CI. Cli. Ada 253, 91, 1996
15. RUTANEN E.M., SEPPALA M.: Insulin binding protein-1 in female reproductive function. /;;J. J. Gyn. Obstet. 39, 3, 1992
16. WORLD HEALTH ORGANIZATION: Manual of the International Classification of diseases injuries and causes of death. Vol. 1, World Health Organization, Geneva, 1977.